Following qRT-PCR analyses (Figure 1A), we observed that NPM1 expression was more pronounced in samples from ATL patients, while no significant increase was noted in HAM/TSP patients (Figure 1A). The gene discussed is NPM1; the disease is tropical spastic paraparesis.